|
Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.
|
|
Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.
|
|
Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders.
|
|
Expert-reviewed information summary about the treatment of childhood acute lymphoblastic leukemia.
|
|
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
|
|
Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
|
|
Expert-reviewed information summary about the treatment of hairy cell leukemia.Hairy cell leukemia is a cancer of the blood and bone marrow. This rare type of leukemia gets worse slowly or not at all. The disease is called hairy cell leukemia because the leukemia cells look "hairy" when viewed under a microscope.
|
|
Myeloproliferative disorders are diseases in which too many of certain types of blood cells are made in the bone marrow. The bone marrow is the spongy tissue inside the large bones in the body. The bone marrow makes red blood cells (which carry oxygen to all the tissues in the body), white blood cells (which fight infection), and platelets (which make the blood clot).
|
|
Myelodysplastic syndromes, also called pre-leukemia or "smoldering” leukemia, are diseases in which the bone marrow does not function normally and not enough normal blood cells are made. The bone marrow is the spongy tissue inside the large bones in the body. The bone marrow makes red blood cells (which carry oxygen and other materials to all tissues of the body), white blood cells (which fight infection), and platelets (which make the blood clot). Normally, bone marrow cells called blasts develop (mature) into several different types of blood cells that have specific jobs in the body.
|
|
Expert-reviewed information summary about the treatment of myelodysplastic/myeloproliferative diseases including chronic/juvenile myelomonocytic leukemias and atypical CML.
|